ANDA 80722, held by Fresenius Kabi USA. Metaraminol Bitartrate.
As of Nov 18, 2026, ANDA 80722 (Metaraminol Bitartrate), held by Fresenius Kabi USA, was first approved by FDA on Apr 17, 1972, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 17, 1972 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Metaraminol BitartrateEQ 10MG BASE/ML · injectable;injection | Metaraminol Bitartrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. “What FDA's review says” is read by a model (Claude Haiku) from FDA's summary review PDF; a field is shown only if its numbers appear in the review, and each section links the review. Drugs@FDA and FDA complete response letters